Diabetes 56:1333-1340, 2007 DOI: 10.2337/db06-1431 © 2007 by the American Diabetes Association Glial Cell–Derived Cytokines Attenuate the Breakdown of Vascular Integrity in Diabetic Retinopathy
1 Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan Address correspondence and reprint requests to Norimasa Sawada, MD, PhD, Department of Pathology, Sapporo Medical University School of Medicine, South 1, West 17, Chuo-ku, Sapporo, Japan 060-8556. E-mail: sawadan{at}sapmed.ac.jp
Abbreviations:
ATRA, all-trans retinoic acid; bMVEC-B, bovine brain microvascular endothelial cell system; BRB, blood-retinal barrier; CBP, CREB binding protein; ChIP, chromatin immunoprecipitation; ELISA, enzyme-linked immunosorbent assay; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; GDNF, glial cell line–derived neurotrophic factor; GDNFr-p, GDNF recombinant protein; GFAP, glial fibrillary acidic protein; RAR, retinoic acid receptor; RET, rearrangement during transfection; siRNA, short interfering RNA; VEGF, vascular endothelial growth factor
The blood-retinal barrier (BRB) is a biological unit comprised of specialized capillary endothelial cells firmly connected by intercellular tight junctions and endothelium-surrounding glial cells. The BRB is essential for maintaining the retinal microenvironment and low permeability and is compromised in an early phase during the progression of diabetic retinopathy. Here, we demonstrate that retinoic acid receptor (RAR)
|
|
|
||||||||||||||||||||||||||